Navigation Links
DMC Cardiovascular Institute First in Midwest to Implant New "Protecta" Defibrillator in a Cardiac Patient
Date:4/5/2011

DETROIT, April 5, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) announced today that it has achieved a significant breakthrough in cardiac heart-care by implanting the newly available "Protecta" defibrillator in a heart-care patient.

The successful procedure, which took place at the DMC March 30, marked the first time that the innovative Protecta device has been implanted in a cardiac patient anywhere in the Midwest.        

The Protecta defibrillator, approved for clinical use by the U.S. Food and Drug Administration (FDA) only eight days ago, is designed to greatly reduce the inappropriate electrical shocks that can occur with traditional defibrillators – often in situations where patients are located near electrical currents or electrical equipment.

According to recent medical research, more than 20 percent of heart-care patients who are outfitted with defibrillators experience such inappropriate shocks at times.  But the new high-tech Protecta was specially designed to virtually eliminate such unwanted electrical impulses in most patients.

Implanted defibrillators are a vital necessity for many heart-care patients who struggle with arrhythmias, since these irregular heartbeats – caused by interruptions in normal electrical heart-signaling – can trigger sudden cardiac death in severe cases.  (More than 350,000 Americans die from these sudden heart attacks each year.)  In the past, however, even the most effective defibrillators often subjected their owners to inappropriate shocks that can interfere with the defibrillation process.

But the successful implantation of the new Protecta at CVI now means that patients who require a defibrillator in order to guard against arrhythmia can also be protected against such accidental shocks.          

.  

"For patients with heartbeat issues that require an implanted defibrillator, this new technology is an important breakthrough," said Randy A. Lieberman, M.D., the Director of Electrophysiology at CVI.  "Our goal at CVI is to keep improving the quality of life for those who need implanted defibrillators, and this pioneering device is a major step on the road to accomplishing that.

"This is a proven technology, FDA-approved, that's been shown to be very effective at eliminating unnecessary shocks.  It's also brand-new – and we were very pleased to learn that we were the first heart-care facility in the entire Midwest to make it available to patents.

"At CVI, we're determined to provide cardiac patients with the very latest heart-care technology.  We want to prolong life with these exciting new tools, that's true – but we also want to improve the quality of life at the same time.  The new Protecta implantable defibrillator is an important step in accomplishing both of those goals."

Dr. Lieberman, who conducted the successful Protecta implantation at DMC Harper University Hospital's Cardiovascular Institute last week, also noted that CVI was recently the first heart-care facility in Michigan to accomplish a transcatheter aortic valve implant, back in February.  That ground-breaking procedure was led by CVI President Theodore L. Schreiber, M.D. and Dr. Ali Kafi, chief of clinical cardio-thoracic surgery at DMC Harper University Hospital.  They were accompanied by a multidisciplinary team of DMC physicians, nurses, research team and technologists.

Describing the recent breakthrough implantation of the Protecta defibrillator, Dr. Schreiber said, "This is certainly a significant treatment advance for patients who need an implanted defibrillator, and it's a very encouraging step forward in helping improve their quality of life."

Added Dr. Schreiber, who was a pioneer in developing the stent procedure for relieving blocked carotid arteries and who currently performs about 1,500 heart and vascular procedures per year at the DMC:  "We're very determined at CVI to bring patients the very latest, cutting-edge heart-care technologies, and it's gratifying to know that we're now able to make Protecta available to any patient who might benefit from it."

Physicians are available for interviews.

For more information, visit www.DMCCVI.org.

About Detroit Medical Center www.dmc.org

The Detroit Medical Center operates nine hospitals and institutes, including Children's Hospital of Michigan, Detroit Receiving Hospital, Harper University Hospital, Huron Valley-Sinai Hospital, Hutzel Women's Hospital, Rehabilitation Institute of Michigan, Sinai-Grace Hospital, DMC Surgery Hospital, and DMC Cardiovascular Institute. The Detroit Medical Center is a leading regional healthcare system with a mission of excellence in clinical care, research and medical education.


'/>"/>
SOURCE Detroit Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medstreaming Launches Fully Integrated Cardiovascular PACS and Certified EMR With Electronic Whiteboard at ACC
2. Siemens Demonstrates Strategy for Sustainable Cardiovascular Care
3. Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
4. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Fujifilms Exclusive Software Advances Cardiovascular Reporting Capabilities
7. Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
8. Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
9. MAQUET Cardiovascular Launches New VASOVIEW 6 PRO Endoscopic Vessel Harvesting System
10. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
11. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
Breaking Medicine News(10 mins):